文献速递心脏核医学

与心脏再同步治疗超反应相关的临床及门控SPECT MPI参数

Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy.
PubMed 文献 · J Nucl Cardiol · 2020-11-05

本研究纳入158例CRT患者,于术前及术后6个月行门控SPECT MPI评估。34例(22%)为超反应者,其术后6个月相位标准差(PSD)显著低于反应者及非反应者。无冠心病史、无糖尿病史及有高血压史为超反应的独立预测因素。

要点

  • CRT术后6个月PSD在超反应者中显著低于反应者及非反应者。
  • 无冠心病史、无糖尿病史为超反应的独立预测因素。
  • 有高血压史亦与超反应独立相关。

核心结论

  • CRT植入后左室机械不同步(以PSD评估)在超反应者中显著优于非超反应者,但基线PSD无此差异。
  • 无糖尿病史、无冠心病史及有高血压史与CRT超反应独立相关。

研究设计与样本

  • 研究纳入158例接受CRT的患者,于CRT前及术后6个月行门控SPECT MPI(gSPECT)评估。
  • 超反应者定义为LVEF改善>15%且NYHA I/II级,或左室收缩末期容积减少>30%且NYHA I/II级。

主要发现

  • 34例(22%)被归类为超反应者。
  • 超反应者术后6个月PSD为32°±17°,低于反应者的45°±24°及非反应者的46°±28°(两项比较P=.02)。
  • 回归分析显示无冠心病史(OR 18.7;P=.002)、无糖尿病史(OR 13;P=.03)及有高血压史(OR .2;P=.01)为超反应的独立预测因素。

关键数值与推荐

  • 超反应判定标准:LVEF改善>15%且NYHA I/II级,或左室收缩末期容积减少>30%且NYHA I/II级。
  • 术后6个月PSD在超反应者为32°±17°,反应者为45°±24°,非反应者为46°±28°(P=.02)。

临床怎么用

  • 门控SPECT MPI所测术后6个月PSD可用于识别CRT超反应者。
  • 无冠心病史、无糖尿病史及有高血压史的患者更可能从CRT中获得超反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to evaluate the behavior of cardiac mechanical synchrony as measured by phase SD (PSD) derived from gated MPI SPECT (gSPECT) in patients with super-response after CRT and to evaluate the clinical and imaging characteristics associated with super-response. METHODS: 158 subjects were evaluated with gSPECT before and 6 months after CRT. Patients with an improvement of LVEF > 15% and NYHA class I/II or reduction in LV end-systolic volume > 30% and NYHA class I/II were labeled as super-responders (SR). RESULTS: 34 patients were classified as super-responders (22%) and had lower PSD (32° ± 17°) at 6 months after CRT compared to responders (45° ± 24°) and non-responders 46° ± 28° (P = .02 for both comparisons). Regression analysis identified predictors independently associated with super-response to CRT: absence of previous history of CAD (odds ratio 18.7; P = .002), absence of diabetes mellitus (odds ratio 13; P = .03), and history of hypertension (odds ratio .2; P = .01). CONCLUSION: LV dyssynchrony after CRT implantation, but not at baseline, was significantly better among super-responders compared to non-super-responders. The absence of diabetes, absence of CAD, and history of hypertension were independently associated with super-response after CRT.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Mesquita CT, Peix A, de Amorim Fernandes F, et al. Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy. J Nucl Cardiol. 2020. PMID: 33152098. doi:10.1007/s12350-020-02414-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。